Jillian Howlin
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
Journal: BMC research notes
Published: November 23, 2022
Pubertal Mammary Gland Development: Elucidation of In Vivo Morphogenesis Using Murine Models.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 01, 2016
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
Journal: EMBO molecular medicine
Published: May 20, 2015
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.
Journal: Oncotarget
Published: January 09, 2015
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
Journal: PeerJ
Published: October 09, 2014
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
Journal: The Journal of investigative dermatology
Published: September 24, 2014
Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass.
Journal: The Journal of investigative dermatology
Published: July 08, 2014
Molecular and genetic diversity in the metastatic process of melanoma.
Journal: The Journal of pathology
Published: August 19, 2013
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
Journal: Molecular oncology
Published: February 21, 2012
TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
Journal: Breast cancer research : BCR
Published: November 21, 2007
Showing 1-10 of 10
Last Updated: 09/26/2026